NRC Health

Good morning, welcome to today's National Research Corporation fourth quarter 2021 earnings conference call. My name is Candice and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for question and answer at the end. If you would like to ask a question you press start followed by one on your telephone keypad. I would now like to pass the conference over to our host Mike Hayes CEO of National Research Corporations. Mike, please go ahead.

Thank you, Candace, and welcome, everyone, to National Research Corporation's 2021 fourth quarter and year-end conference call. My name is Mike Hayes, the company's CEO, and joining me on the call today is Kevin Karras, our chief financial officer. Before we continue, I'd ask Kevin to review conditions related to any forward-looking statements that may be made as part of today's call. Kevin?

Thank you, Mike. This conference call includes forward-looking statements related to the company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the company's future results. Please see the company's filings with the Securities and Exchange Commission. With that, I'll turn it back to you, Mike.